Ryan David P. bought CGEM
June 12, 2025 · Form 4 insider transaction
Ryan David P. bought 38,513 shares of Cullinan Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
38,513
Price
$0.00
Total value
N/A
InsiderRyan David P.
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 12, 2025
Filing dateJune 16, 2025
Shares owned after38,513
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option represents a right to purchase a total of 38,513 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 12, 2026 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date